Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Kitzis

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Pathologie-Biologie|May 1, 1991
[In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve]C J Soussy, M D Kitzis, C Chanal, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitorsX Y Zhou, F Bordon, D Sirot, et al.
Pathologie-Biologie|June 1, 1982
[Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]R Nasnas, L Gutmann, M D Kitzis, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1989
In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteriaM D Kitzis, B Ferré, A Coutrot, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniaeV Zeller, C Janoir, M D Kitzis, et al.
Pathologie-Biologie|May 1, 1994
[In vitro antibacterial activity of a new fluoroquinolone, fleroxacin, against hospital bacteria and regression curve]C J Soussy, M Cluzel, E Derlot, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamaseG Leleu, M D Kitzis, J M Vallois, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1994
Mechanisms of failure to decontaminate the gut with polymixin E, gentamicin and amphotericin B in patients in intensive careB Misset, M D Kitzis, G Conscience, et al.
Pathologie-Biologie|May 1, 1989
[Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose]J Guibert, M D Kitzis, J F Acar, et al.
Reviews of Infectious Diseases|January 1, 1979
Penetration of cefoxitin into cerebrospinal fluid of dogs with and without experimental meningitisP Massip, M D Kitzis, V T Tran, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Pathologie-Biologie|May 1, 1991
[In vitro antibacterial activity of piperacillin-tazobactam combination on hospital isolates and regression curve]C J Soussy, M D Kitzis, C Chanal, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1994
Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitorsX Y Zhou, F Bordon, D Sirot, et al.
Pathologie-Biologie|June 1, 1982
[Comparative study of ceftriaxone, cefotaxime and moxalactam against 150 Gram negative strains (author's transl)]R Nasnas, L Gutmann, M D Kitzis, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|September 1, 1989
In vitro activity of combinations of beta-lactam antibiotics with beta-lactamase inhibitors against cephalosporinase-producing bacteriaM D Kitzis, B Ferré, A Coutrot, et al.
Antimicrobial Agents and Chemotherapy|September 26, 1997
Active efflux as a mechanism of resistance to ciprofloxacin in Streptococcus pneumoniaeV Zeller, C Janoir, M D Kitzis, et al.
Pathologie-Biologie|May 1, 1994
[In vitro antibacterial activity of a new fluoroquinolone, fleroxacin, against hospital bacteria and regression curve]C J Soussy, M Cluzel, E Derlot, et al.
Antimicrobial Agents and Chemotherapy|February 1, 1994
Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamaseG Leleu, M D Kitzis, J M Vallois, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|February 1, 1994
Mechanisms of failure to decontaminate the gut with polymixin E, gentamicin and amphotericin B in patients in intensive careB Misset, M D Kitzis, G Conscience, et al.
Pathologie-Biologie|May 1, 1989
[Antibacterial activity of lomefloxacin in the urine during the 4 days following a single 400 mg oral dose]J Guibert, M D Kitzis, J F Acar, et al.
Reviews of Infectious Diseases|January 1, 1979
Penetration of cefoxitin into cerebrospinal fluid of dogs with and without experimental meningitisP Massip, M D Kitzis, V T Tran, et al.
Pageof 9